Antimalarial drug efficacy and resistance in malaria‐endemic countries in HANMAT‐PIAM_net countries of the Eastern Mediterranean Region 2016–2020: Clinical and genetic studies

Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study

(2021) Aline Uwimana et al.   LANCET INFECTIOUS DISEASES

Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan

(2021) Najia Karim Ghanchi et al.   MALARIA JOURNAL

Current and emerging strategies to combat antimalarial resistance

(2021) Charlotte Rasmussen et al.   Expert Review of Anti-Infective Therapy

Evidence of Artemisinin-Resistant Malaria in Africa

(2021) Betty Balikagala et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018

(2020) Xiaoxiao Wang et al.   MALARIA JOURNAL

Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan

(2020) Abdelrahim O. Mohamed et al.   MALARIA JOURNAL

Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia

(2020) Melissa Mairet-Khedim et al.   CLINICAL INFECTIOUS DISEASES

Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019

(2020) Abdul Qader Khan et al.   MALARIA JOURNAL

Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015–2017

(2020) Maazza Hussien et al.   PLoS One

Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy

(2020) Aymen M. Madkhali et al.   MALARIA JOURNAL

Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

(2020) Aditi Arya et al.   International Journal for Parasitology-Drugs and Drug Resistance

African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker

(2019) Didier Leroy et al.   MALARIA JOURNAL

Absence of K13 gene mutations among artesunate/sulfadoxine–pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan

(2019) Muzamil M Abdel Hamid et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Improving methods for analysing anti-malarial drug efficacy trials: molecular correction based on length-polymorphic markers msp-1, msp-2 and glurp.

(2019) S. Jones et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

(2019) Rob W van der Pluijm et al.   LANCET INFECTIOUS DISEASES

High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia

(2019) Marian Warsame et al.   MALARIA JOURNAL

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan

(2018) Adnan Yaqoob et al.   MALARIA JOURNAL

Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study

(2017) Roberto Amato et al.   LANCET INFECTIOUS DISEASES

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study

(2017) Benoit Witkowski et al.   LANCET INFECTIOUS DISEASES

Efficacies of DHA–PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan

(2017) Abdelrahim O. Mohamed et al.   MALARIA JOURNAL

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin–piperaquine in the south of Vietnam

(2017) Ngo Viet Thanh et al.   MALARIA JOURNAL

Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine anddhfranddhpsmutations in Somalia: evidence for updating the malaria treatment policy

(2017) Marian Warsame et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Antimalarial Drug Resistance: A Threat to Malaria Elimination

(2017) Didier Menard et al.   Cold Spring Harbor Perspectives in Medicine

Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007–2015): In vivo response and dhfr and dhps mutations

(2016) Qutbuddin Kakar et al.   ACTA TROPICA

A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia

(2016) Abebe Genetu Bayih et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Declining Efficacy of Artemisinin Combination Therapy AgainstP. FalciparumMalaria on the Thai–Myanmar Border (2003–2013): The Role of Parasite Genetic Factors

(2016) Aung Pyae Phyo et al.   CLINICAL INFECTIOUS DISEASES

Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study

(2016) Chanaki Amaratunga et al.   LANCET INFECTIOUS DISEASES

High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010–2015): evidence from in vivo and molecular marker studies

(2016) Ahmed A. Adeel et al.   MALARIA JOURNAL

Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes

(2016) Wahib M. Atroosh et al.   MALARIA JOURNAL

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction

(2016) Ghulam Rahim Awab et al.   MALARIA JOURNAL

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker

(2015) Kyaw M Tun et al.   LANCET INFECTIOUS DISEASES

High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen

(2015) Ahmed A. Adeel et al.   MALARIA JOURNAL

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

(2014) Elizabeth A. Ashley et al.   NEW ENGLAND JOURNAL OF MEDICINE

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

(2013) Frédéric Ariey et al.   NATURE

Artemisinin Resistance inPlasmodium falciparumMalaria

(2009) Arjen M. Dondorp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment

(2009) Verena Ilona Carrara et al.   PLoS One